Geoffrey M. Raux

Geoffrey M. Raux is a partner at Foley & Lardner LLP, focusing his practice on complex commercial and health care litigation, with a notable emphasis on patent litigation in the life sciences and biotechnology sectors. His work includes disputes involving licensing issues and trade secrets. His tracked cases demonstrate a consistent representation of plaintiffs in patent infringement matters, with all two recorded appearances on the plaintiff side.

Mr. Raux has served as lead counsel for 10x Genomics, Inc. and President and Fellows of Harvard College in significant patent disputes. These include 10x Genomics, Inc. et al. v. Vizgen, Inc. and 10x Genomics, Inc. et al. v. NanoString Technologies, Inc. In the case against NanoString Technologies, 10x Genomics was awarded $31 million in patent infringement damages by the District of Delaware in November 2023, and also secured a preliminary injunction against certain products. The parties subsequently reached a worldwide settlement in May 2025. He also appeared for President and Fellows of Harvard College in Bio-Rad Laboratories, Inc. et al v. 10X Genomics, Inc.

While his practice areas encompass commercial litigation and trade secret disputes, there is no public information to indicate regular appearances in PTAB or IPR proceedings.

Mr. Raux earned his J.D. from Harvard Law School, where he was a member of the Harvard International Law Journal, and received his B.A., summa cum laude, from Syracuse University. He is admitted to practice in Massachusetts, New York, and Rhode Island, as well as before the First Circuit Court of Appeals, the D.C. Court of Appeals, and several federal district courts.